mGlu5 receptor deletion does not confer seizure protection to mice

Life Sciences

Volumn 83, Issue 9-10, 2008, Pages 377-380

  Witkin, Jeffrey M ^a   Baez, Melvyn ^a   Yu, Jianliang ^a   Eiler II, William J A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Epilepsy; mGlu5 receptors; Mice; MTEP; Seizures

Indexed keywords

3 [(2 METHYL 4 THIAZOLYL)ETHYNYL]PYRIDINE; 4 AMINOPYRIDINE; AMINOPHYLLINE; COCAINE; DIZOCILPINE; KAINIC ACID; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINE; PENTETRAZOLE; STRYCHNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DRUG DOSE COMPARISON; GENE DELETION; KNOCKOUT MOUSE; LETHALITY; MALE; MOUSE; NONHUMAN; SEIZURE; TONIC CLONIC SEIZURE; TREATMENT RESPONSE; WILD TYPE;

ANIMALS; CONVULSANTS; MALE; MICE; MICE, KNOCKOUT; RECEPTORS, METABOTROPIC GLUTAMATE; SEIZURES;

MUS; STRYCHNOS TOXIFERA;

EID: 49549095318     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.07.001     Document Type: Article

References (26)

1. Barton M.E., Peters S.C., and Shannon H.E. Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models. Epilepsy Research 56 (2003) 17-26
2. Battaglia G., Busceti C.L., Molinaro G., Biagioni F., Storto M., Fornai F., Nicoletti F., and Bruno V. Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Journal of Neuroscience 24 4 (2004) 828-835
3. Bradford H.F. Glutamate, GABA and epilepsy. Progress in Neurobiology 47 (1995) 477-511
4. Busse C.S., Brodkin J., Tattersall D., Anderson J.J., Warren N., Tehrani L., Bristow L.J., Varney M.A., and Cosford N.D. The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety. Neuropsychopharmacology 29 (2004) 1971-1979
5. Chapman A.G., Nanan K., Williams M., and Meldrum B.S. Anticonvulsant activity of two metabotropic glutamate group I antagonists selective for the mGlu5 receptor: 2-methyl-6-(phenylethynyl)-pyridine (MPEP), and (E)-6-methyl-2-styryl-pyridine (SIB 1893). Neuropharmacology 39 9 (2000) 1567-1574
6. Chiamulera C., Epping-Jordan M.P., Zocchi A., Marcon C., Cottiny C., Tacconi S., Corsi M., Orzi F., and Conquet F. Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nature Neuroscience 4 (2001) 873-874
7. Conn P.J., and Pin J.P. Pharmacology and functions of metabotropic glutamate receptors. Annual Review of Pharmacology and Toxicology 37 (1997) 205-237
8. Cosford N.D., Roppe J., Tehrani L., Schweiger E.J., Seiders T.J., Chaudary A., Rao S., and Varney M.A. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity. Journal of Medicinal Chemisty 46 (2003) 204-206
9. Jesse C.R., Savegnago L., Rocha J.B., and Nogueira C.W. Neuroprotective effect caused by MPEP, an antagonist of metabotropic glutamate receptor mGluR5, on seizures induced by pilocarpine in 21-day-old rats. Brain Research 1198 (2008) 197-203
10. Jia Z., Lu Y., Henderson J., Taverna F., Romano C., Abramow-Newerly W., Wojtowicz J.M., and Roder J. Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. Learning and Memory 5 (1998) 331-343
11. Klodzinska A., Tatarczynska E., Chojnacka-Wojcik E., Nowak G., Cosford N.D., and Pilc A. Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling. Neuropharmacology 47, 342-350. Erratum in: Neuropharmacology 47 (2004) 1115
12. Lea IV P.M., Movsesyan V.A., and Faden A.I. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. British Journal of Pharmacology 145 4 (2005) 527-534
13. Leander J.D., Lawson R.R., Ornstein P.L., and Zimmerman D.M. N-methyl-d-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs. Brain Research 448 1 (1988) 115-120
14. Li X., Need A.B., Baez M., and Witkin J.M. Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice. Journal of Pharmacology and Expimental Therapeutics 319 1 (2006) 254-259
15. Loscher W., Dekundy A., Nagel J., Danysz W., Parsons C.G., and Potschka H. mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy. Neuropharmacology 50 8 (2006) 1006-1015
16. Mares P., and Mikulecká A. MPEP, an antagonist of metabotropic glutamate receptors, exhibits anticonvulsant action in immature rats without a serious impairment of motor performance. Epilepsy Research 60 1 (2004) 17-26
17. Moldrich R.X., Chapman A.G., De Sarro G., and Meldrum B.S. Glutamate metabotropic receptors as targets for drug therapy in epilepsy. European Journal of Pharmacology 476 1-2 (2003) 3-16
18. Palucha A., Branski P., Szewczyk B., Wieronska J.M., Klak K., and Pilc A. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist. Pharmacology Biochemistry and Behavior 81 (2005) 901-906
19. Pisani A., Bonsi P., Picconi B., Tolu M., Giacomini P., and Scarnati E. Role of tonically-active neurons in the control of striatal function: cellular mechanisms and behavioral correlates. Progress in Neuropsychopharmacology and Biological Psychiatry 25 1 (2001) 211-230
20. Romano C., Smout S., Miller J.K., and O'Malley K.L. Developmental regulation of metabotropic glutamate receptor 5b protein in rodent brain. Neuroscience. 111 3 (2002) 693-698
21. Schoepp D.D., and Conn P.J. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol Sci 14 (1993) 13-20
22. Schoepp D.D., Jane D.E., and Monn J.A. Pharmacological agents acting at subtypes of metabotropic glutamate receptors. Neuropharmacology. 38 10 (1999) 1431-1476
23. Smolders I., Lindekens H., Clinckers R., Meurs A., O'Neill M.J., Lodge D., Ebinger G., and Michotte Y. In vivo modulation of extracellular hippocampal glutamate and GABA levels and limbic seizures by group I and II metabotropic glutamate receptor ligands. Journal of Neurochemistry 88 (2004) 1068-1077
24. Stoop R., Conquet F., Zuber B., Voronin L.L., and Pralong E. Activation of metabotropic glutamate 5 and NMDA receptors underlies the induction of persistent bursting and associated long-lasting changes in CA3 recurrent connections. J Neurosci. 23 13 (2003) 5634-5644
25. Tang F.R., Chen P.M., Tang Y.C., Tsai M.C., and Lee W.L. Two-methyl-6-phenylethynyl-pyridine (MPEP), a metabotropic glutamate receptor 5 antagonist, with low doses of MK801 and diazepam: a novel approach for controlling status epilepticus. Neuropharmacology 53 7 (2007 Dec) 821-831
26. Zadrozniak M., Sekowski A., Czuczwar S.J., and Borowicz K.K. Effect of MPEP, a selective mGluR5 antagonist, on the antielectroshock activity of conventional antiepileptic drugs. Polish Journal of Pharmacology 56 5 (2004) 595-598